Parkinson’s Disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting 2–3 % of individuals aged 65 and older and an estimated 7–10 million people worldwide [1,2]. Clinically, PD is categorized into Tremor-Dominant (TD), Postural Instability and Gait Difficulty (PIGD), and mixed subtypes based on the MDS Unified Parkinson’s Disease Rating Scale (UPDRS). PIGD progresses more rapidly, is associated with more non-motor symptoms, and responds less effectiv…